Protein disulfide isomerase as an antithrombotic target

Trends in Cardiovascular Medicine

Volumn 23, Issue 7, 2013, Pages 264-268

  Flaumenhaft, Robert ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BACITRACIN; FLAVONOID; PROTEIN DISULFIDE ISOMERASE; QUERCETIN; RUTOSIDE;

ANTICOAGULATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; HUMAN; IC 50; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; STOMACH LAVAGE; STRUCTURE ACTIVITY RELATION; THROMBOCYTE ACTIVATION; THROMBOSIS; THROMBUS;

ANIMALS; BLOOD PLATELETS; DRUG DISCOVERY; ENDOPLASMIC RETICULUM; ENDOTHELIAL CELLS; FIBRINOLYTIC AGENTS; HUMANS; MODELS, CARDIOVASCULAR; PROTEIN DISULFIDE-ISOMERASES; RUTIN; THROMBOSIS;

EID: 84883794015     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2013.03.001     Document Type: Review

References (35)

1. Appenzeller-Herzog C., Ellgaard L. The human PDI family: versatility packed into a single fold. Biochimica et Biophysica Acta 2008, 1783(4):535-548.
2. Burgess J.K., Hotchkiss K.A., Suter C., Dudman N.P., Szollosi J., Chesterman C.N., et al. Physical proximity and functional association of glycoprotein 1balpha and protein-disulfide isomerase on the platelet plasma membrane. Journal of Biological Chemistry 2000, 275(13):9758-9766.
3. Chen K., Lin Y., Detwiler T.C. Protein disulfide isomerase activity is released by activated platelets. Blood 1992, 79(9):2226-2228.
4. Chen V.M., Ahamed J., Versteeg H.H., Berndt M.C., Ruf W., Hogg P.J. Evidence for activation of tissue factor by an allosteric disulfide bond. Biochemistry 2006, 45(39):12020-12028.
5. Cho J., Furie B.C., Coughlin S.R., Furie B. A critical role for extracellular protein disulfide isomerase during thrombus formation in mice. Journal of Clinical Investigation 2008, 118(3):1123-1131.
6. Cho J., Kennedy D.R., Lin L., Huang M., Merrill-Skoloff G., Furie B.C., et al. Protein disulfide isomerase capture during thrombus formation in vivo depends on the presence of beta3 integrins. Blood 2012, 120(3):647-655.
7. Essex D.W., Chen K., Swiatkowska M. Localization of protein disulfide isomerase to the external surface of the platelet plasma membrane. Blood 1995, 86(6):2168-2173.
8. Essex D.W., Li M. A polyclonal antibody to protein disulfide isomerase induces platelet aggregation and secretion. Thrombosis Research 1999, 96(6):445-450.
9. Essex D.W., Li M. Protein disulphide isomerase mediates platelet aggregation and secretion. British Journal of Haematology 1999, 104(3):448-454.
10. Essex D.W., Li M., Miller A., Feinman R.D. Protein disulfide isomerase and sulfhydryl-dependent pathways in platelet activation. Biochemistry 2001, 40(20):6070-6075.
11. Geleijnse J.M., Launer L.J., Hofman A., Pols H.A., Witteman J.C. Tea flavonoids may protect against atherosclerosis: the Rotterdam study. Archives of Internal Medicine 1999, 159(18):2170-2174.
12. Geleijnse J.M., Launer L.J., Van der Kuip D.A., Hofman A., Witteman J.C. Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam study. American Journal of Clinical Nutrition 2002, 75(5):880-886.
13. Giannakopoulos B., Gao L., Qi M., Wong J.W., Yu D.M., Vlachoyiannopoulos P.G., et al. Factor XI is a substrate for oxidoreductases: enhanced activation of reduced FXI and its role in antiphospholipid syndrome thrombosis. Journal of Autoimmunity 2012, 39(3):121-129.
14. Holbrook L.M., Sasikumar P., Stanley R.G., Simmonds A.D., Bicknell A.B., Gibbins J.M. The platelet-surface thiol isomerase enzyme ERp57 modulates platelet function. Journal of Thrombosis and Haemostasis 2012, 10(2):278-288.
15. Holbrook L.M., Watkins N.A., Simmonds A.D., Jones C.I., Ouwehand W.H., Gibbins J.M. Platelets release novel thiol isomerase enzymes which are recruited to the cell surface following activation. British Journal of Haematology 2010, 148(4):627-637.
16. Jasuja R., Furie B., Furie B.C. Endothelium-derived but not platelet-derived protein disulfide isomerase is required for thrombus formation in vivo. Blood 2010, 116(22):4665-4674.
17. Jasuja R., Passam F.H., Kennedy D.R., Kim S.H., van Hessem L., Lin L., et al. Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents. Journal of Clinical Investigation 2012, 122(6):2104-2113.
18. Jordan P.A., Stevens J.M., Hubbard G.P., Barrett N.E., Sage T., Authi K.S., et al. A role for the thiol isomerase protein ERP5 in platelet function. Blood 2005, 105(4):1500-1507.
19. Khan M.M., Simizu S., Lai N.S., Kawatani M., Shimizu T., Osada H. Discovery of a small molecule PDI inhibitor that inhibits reduction of HIV-1 envelope glycoprotein gp120. ACS Chemical Biology 2011, 6(3):245-251.
20. Kyrle P.A., Minar E., Bialonczyk C., Hirschl M., Weltermann A., Eichinger S. The risk of recurrent venous thromboembolism in men and women. New England Journal of Medicine 2004, 350(25):2558-2563.
21. Lahav J., Wijnen E.M., Hess O., Hamaia S.W., Griffiths D., Makris M., et al. Enzymatically catalyzed disulfide exchange is required for platelet adhesion to collagen via integrin alpha2beta1. Blood 2003, 102(6):2085-2092.
22. Lame M.W., Jones A.D., Wilson D.W., Segall H.J. Monocrotaline pyrrole targets proteins with and without cysteine residues in the cytosol and membranes of human pulmonary artery endothelial cells. Proteomics 2005, 5(17):4398-4413.
23. Lovat P.E., Corazzari M., Armstrong J.L., Martin S., Pagliarini V., Hill D., et al. Increasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stress. Cancer Research 2008, 68(13):5363-5369.
24. Mandel R., Ryser H.J., Ghani F., Wu M., Peak D. Inhibition of a reductive function of the plasma membrane by bacitracin and antibodies against protein disulfide-isomerase. Proceedings of the National Academy of Sciences of the United States of America 1993, 90(9):4112-4116.
25. McCullough M.L., Peterson J.J., Patel R., Jacques P.F., Shah R., Dwyer J.T. Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. American Journal of Clinical Nutrition 2012, 95(2):454-464.
26. Nagarakanti R., Sodhi S., Lee R., Ezekowitz M. Chronic antithrombotic therapy in post-myocardial infarction patients. Cardiology Clinics 2008, 26(2):277-288. vii.
27. Reinhardt C., von Bruhl M.L., Manukyan D., Grahl L., Lorenz M., Altmann B., et al. Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation. Journal of Clinical Investigation 2008, 118(3):1110-1122.
28. Rogelj S., Reiter K.J., Kesner L., Li M., Essex D. Enzyme destruction by a protease contaminant in bacitracin. Biochemical and Biophysical Research Communications 2000, 273(3):829-832.
29. Ruf W. Role of thiol pathways in TF procoagulant regulation. Thrombosis Research 2012, 129(Suppl. 2):S11-S12.
30. Santos C.X., Stolf B.S., Takemoto P.V., Amanso A.M., Lopes L.R., Souza E.B., et al. Protein disulfide isomerase (PDI) associates with NADPH oxidase and is required for phagocytosis of Leishmania chagasi promastigotes by macrophages. Journal of Leukocyte Biology 2009, 86(4):989-998.
31. Smith A.M., Chan J., Oksenberg D., Urfer R., Wexler D.S., Ow A., et al. A high-throughput turbidometric assay for screening inhibitors of protein disulfide isomerase activity. Journal of Biomolecular Screening 2004, 9(7):614-620.
32. Thon J.N., Peters C.G., Machlus K.R., Aslam R., Rowley J., Macleod H., et al. T granules in human platelets function in TLR9 organization and signaling. Journal of Cell Biology 2012, 198(4):561-574.
33. Walle T. Absorption and metabolism of flavonoids. Free Radical Biology and Medicine 2004, 36(7):829-837.
34. Wu Y., Ahmad S.S., Zhou J., Wang L., Cully M.P., Essex D.W. The disulfide isomerase ERp57 mediates platelet aggregation, hemostasis, and thrombosis. Blood 2012, 119(7):1737-1746.
35. Xu S., Butkevich A.N., Yamada R., Zhou Y., Debnath B., Duncan R., et al. Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian cancer treatment. Proceedings of the National Academy of Sciences of the United States of America 2012, 109(40):16348-16353.